Being born too soon is now the second-leading killer of children under the age of five, worldwide. The World Health Organisation (WHO) is concerned that preterm birth rates are increasing in many countries.
INFANT focuses on how technology and medicine can improve the health outcomes for neonates (infants less than four weeks old). INFANT’s groundbreaking research in this field meets the need for the accurate identification and reduction of severe neonatal complications.
The CATePILLaR Study is evaluating the impact of COVID-19 restrictions on mother & baby’s health and wellbeing.
Cerebral regional tissue Oxygen Saturation to Guide Oxygen Delivery
in preterm neonates during immediate transition after birth
Multimodal Assessment of Newborns at Risk of Neonatal Hypoxic Ischaemic Encephalopathy –The MONItOr Study